Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 20
1982 25
1983 41
1984 47
1985 59
1986 65
1987 80
1988 70
1989 95
1990 71
1991 56
1992 90
1993 71
1994 66
1995 97
1996 81
1997 76
1998 83
1999 71
2000 58
2001 61
2002 71
2003 66
2004 74
2005 76
2006 75
2007 79
2008 68
2009 84
2010 106
2011 85
2012 74
2013 92
2014 76
2015 98
2016 83
2017 87
2018 68
2019 54
2020 112
2021 184
2022 177
2023 205
2024 86

Text availability

Article attribute

Article type

Publication date

Search Results

3,342 results

Results by year

Filters applied: . Clear all
Page 1
Axial length targets for myopia control.
Chamberlain P, Lazon de la Jara P, Arumugam B, Bullimore MA. Chamberlain P, et al. Ophthalmic Physiol Opt. 2021 May;41(3):523-531. doi: 10.1111/opo.12812. Epub 2021 May 5. Ophthalmic Physiol Opt. 2021. PMID: 33951213 Free PMC article. Clinical Trial.
COVID-19 and myopia.
Rosenfield M. Rosenfield M. Ophthalmic Physiol Opt. 2022 Mar;42(2):255-257. doi: 10.1111/opo.12944. Epub 2022 Jan 11. Ophthalmic Physiol Opt. 2022. PMID: 35014078 No abstract available.
Authors' Reply.
Sevik MO, Çam F, Aykut A, Dericioğlu V, Şahin Ö. Sevik MO, et al. Ophthalmic Physiol Opt. 2022 Jul;42(4):932-933. doi: 10.1111/opo.12993. Epub 2022 May 5. Ophthalmic Physiol Opt. 2022. PMID: 35510936 No abstract available.
Author's reply.
Wu YT, Ho A, Naduvilath T, Lim C, Carnt N, Keay LJ, Edwards KP, Stapleton F. Wu YT, et al. Ophthalmic Physiol Opt. 2021 Nov;41(6):1387-1388. doi: 10.1111/opo.12883. Epub 2021 Sep 8. Ophthalmic Physiol Opt. 2021. PMID: 34496077 No abstract available.
Author's reply.
Chamberlain P, Bullimore MA. Chamberlain P, et al. Ophthalmic Physiol Opt. 2021 Nov;41(6):1384. doi: 10.1111/opo.12872. Epub 2021 Aug 17. Ophthalmic Physiol Opt. 2021. PMID: 34402540 No abstract available.
Gene-environment interaction in myopia.
He X, Li SM. He X, et al. Ophthalmic Physiol Opt. 2023 Nov;43(6):1438-1448. doi: 10.1111/opo.13206. Epub 2023 Jul 24. Ophthalmic Physiol Opt. 2023. PMID: 37486033 Review.
Pharmacological treatment of presbyopia.
Rosenfield M. Rosenfield M. Ophthalmic Physiol Opt. 2022 Jul;42(4):663-665. doi: 10.1111/opo.12995. Epub 2022 May 2. Ophthalmic Physiol Opt. 2022. PMID: 35499127 No abstract available.
The peer review process.
Rosenfield M. Rosenfield M. Ophthalmic Physiol Opt. 2023 Nov;43(6):1319-1320. doi: 10.1111/opo.13233. Epub 2023 Sep 12. Ophthalmic Physiol Opt. 2023. PMID: 37697933 No abstract available.
Author's Reply.
Swystun AG, Davey CJ. Swystun AG, et al. Ophthalmic Physiol Opt. 2022 May;42(3):660-661. doi: 10.1111/opo.12953. Epub 2022 Jan 29. Ophthalmic Physiol Opt. 2022. PMID: 35094418 No abstract available.
3,342 results